California Fines GM’s Cruise for Delayed Reporting on Accidentby Mark Eisenberg 21.06.2024California fines GM's Cruise $112,500 for delayed accident reporting; regulatory scrutiny tightens for self-driving car safety compliance.
Apple-Affirm Deal Could Boost GMV by 35%, Says Mizuhoby Mark Eisenberg 21.06.2024"Mizuho analysis: Apple-Affirm partnership could boost BNPL volume by 35%, adding $12 billion by FY25, potentially justifying Affirm's stock surge."
US to Ban Kaspersky Software Sales, Reports Indicateby Lilu Anderson 20.06.2024US to ban Kaspersky antivirus over national security risks, citing alleged Russian ties. Move prevents sales, aims to protect infrastructure.
Greece Stocks Decline: Athens General Composite Down 0.31%by Mark Eisenberg 20.06.2024Greece stocks closed lower on Thursday with the Athens General Composite down 0.31%. Iktinos Hellas rose 4.72%, while Motor Oil ...
US Supreme Court Rules Against Couple in Taxation Caseby Mark Eisenberg 20.06.2024"US Supreme Court rules 7-2 against Washington couple in foreign investment taxation case, supporting Mandatory Repatriation Tax. Narrow decision."
Crypto Assets Soar: BTC Hits $66K Amid ETF Debut on ASXby John Darbie 20.06.2024Crypto assets rise as Bitcoin hits $66K, VanEck Bitcoin ETF debuts on ASX, and AI-linked tokens surge 35% amid Nvidia ...
Honeywell Acquires CAES Systems for $1.9B in Defense Sector Boostby Mark Eisenberg 20.06.2024Honeywell to acquire CAES Systems for $1.9B to bolster its aerospace technologies amid global defense demands. Deal expected to close ...
AI Investments: Hype vs. Reality in 2024by Lilu Anderson 20.06.2024Are investors starting to see through AI hype? Some tech firms thrive, but many falter as market demands real results ...
Analysts Baffled as Bitcoin Hits ATH Amid User Declineby John Darbie 20.06.2024"IntoTheBlock reveals puzzling Bitcoin trend: high network activity but low new user adoption sees BTC price stagnate despite ATH."
Fortress Biotech Sees Upgrades Amid Investor Shiftsby Lilu Anderson 20.06.2024"Fortress Biotech (FBIO) upgraded to 'Hold' by StockNews.com amid 5.8% decline; analysts offer mixed ratings as hedge funds increase stakes."